Skip to main content
The Convergence
Sponsors Jump to a planet… AI & Robotics AI Marketplace AI Responsibility Health & Wellness Sports Entertainment Breaking News Finance & Investing Gaming Automotive Shopping Business Archive Dark Planet Real Estate & Housing Space & Aerospace Fashion & Beauty History Home & DIY True Crime Alternative & Natural Medicine Celebrities / Pop Culture Food & Recipes Travel
Home / AI & Robotics / Human Integration
Human Integration: where AI & robotics meet medicine
Not general health coverage — specifically where AI and robotic systems physically or cognitively integrate with the human body. For general wellness and longevity, see the Human Health planet.
Overview AI Robotics Infrastructure Power & Energy Human Integration AI Toolkit AI Marketplace Nanotechnology
Related: Health & Wellness (the biology side of this story) →
Bioelectric "reprogramming" is treating cancer as an information problem, not just a genetic one
Dr. Michael Levin, a Tufts University professor with degrees in both computer science and biology, directs research into bioelectricity — the electrical signaling network cells use to coordinate as a single organism rather than acting independently. His team's core finding: cancer cells that get reconnected to the bioelectric "conversation" of surrounding healthy tissue can normalize — they behave again as part of the organ, and tumor growth slows or reverses, without editing a single gene. It's a genuinely different approach from most cancer research, treating malignancy as cells that stopped receiving the right electrical signal rather than purely a DNA mutation problem. Levin's lab is also known for creating xenobots, the first living robots built from frog skin cells.
Source: Levin Lab, Tufts University →
Surgical robots are becoming semi-autonomous partners
Systems like the da Vinci platform, with 3D vision and dual-console operation, have already advanced minimally invasive surgery, and remote-surgery systems now enable operations performed from a distance. The direction of travel is clear: surgical robots are evolving from teleoperated tools that a surgeon fully controls into intelligent partners capable of semi-autonomous or autonomous actions in specific steps of a procedure.
Source: Intuitive Surgical newsroom →
Brain-computer interfaces crossed a real threshold in 2026
People with ALS, locked-in syndrome, and high spinal cord injuries are now using AI-decoded brain implants to type and control devices at speeds approaching natural communication. Speech-decoding systems have pushed word error rates below 5% — a level considered clinically viable as a primary communication method, not just a research demo.
Source: BrainGate publications →
Exoskeletons paired with BCI are accelerating stroke recovery
Rehabilitation systems that combine motor-imagery training with robotic exoskeleton feedback are speeding up recovery from stroke and traumatic brain injury by directly engaging the brain's own neuroplasticity — the exoskeleton acts on intention decoded straight from neural signals, not just physical assistance.
Source: BrainGate publications →
China grants the world's first regulatory approval for an implantable BCI
China's National Medical Products Administration approved the world's first implantable brain-computer interface device for medical use in 2026 — a genuine regulatory first that moves BCI technology from laboratory research into approved clinical application. The device works by collecting and interpreting neural electrical signals generated during brain activity and translating them into commands that let users control external devices using thought alone. No BCI device has yet received equivalent commercial approval in the US: Neuralink and Synchron are both pursuing FDA pathways, but realistic timelines for limited commercial availability in the US run to 2028-2030, even as the FDA has extended Breakthrough Device Designation (a fast-track review pathway) to BCI systems from Neuralink, Synchron, CorTec, and Blackrock Neurotech.
Source: People's Daily / clinical trial registries →
Neuralink's real 2026 numbers: 45 participants, 1,024 electrodes, and a speech-decoding rival closing the gap
By mid-2026, Neuralink reported enrolling 45 participants across three continents in its PRIME study, using a custom-built neurosurgical robot to implant up to 1,024 ultra-thin polymer electrode threads — each thinner than a human hair — into the motor cortex. Its first public patient, Noland Arbaugh, demonstrated playing chess and browsing the web using thought-controlled cursor movement alone. Academically, BrainGate's parallel research has pushed further into speech: a rapid-calibration intracortical typing neuroprosthesis reached 22 words per minute with a 1.6% word error rate for paralyzed patients, and separate BrainGate work translated attempted speech into text at rates approaching 60 words per minute — both genuinely close to natural communication speed rather than a proof-of-concept curiosity. Real caveat worth keeping in view: no BCI is commercially available anywhere in the US as of 2026 — every current implant operates under a research protocol or expanded access program.
Source: Applying AI / Neuroba →
Human Integration Directory
Intuitive Surgical
da Vinci surgical robot platform
Neuralink
Brain-computer interface implants (private)
BrainGate
BCI research consortium (nonprofit)
+ your company here
THE CONVERGENCE · theconvergencehub.com · Not investment advice, not medical advice · About · Privacy · Terms · YouTube · TikTok · Facebook